Titan Biotech has announced its maiden 1:4 bonus issue, with one share to be issued for every four held, subject to shareholder approval. The multibagger stock has gained over 200% in a year and 100% in 2026. Here’s what investors need to know about the bonus issue and eligibility.
Titan Biotech has announced its maiden 1:4 bonus issue, with one share to be issued for every four held, subject to shareholder approval. The multibagger stock has gained over 200% in a year and 100% in 2026. Here’s what investors need to know about the bonus issue and eligibility.
<iframe src="https://hindustansphere.com/embed/cluster/863e25c53e4e5c2d6adc87fb02e3ca9db38e2fe6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Bonus issue alert! Multibagger Titan Biotech announces its maiden 1:4 bonus issue"></iframe>
